Tapewire

Nasdaq · USD

CNSY

CERENOME, INC.

Export transactions ↓
Tapewire entity
7637
SEC CIK
0001095981
Parsed reports
179

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2025 Filed Feb 20, 2025 22:30 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 60,020 $0.00 Strike: $1.18 $0.00
Disclosure

SEC source: 0000950170-25-024337 · ownership.xml · derivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,020

Underlying: Common Stock · 60,020 shares

Expires 2035-02-17

F1 · derivative.exercise_date: (1) The option vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 40,122 $0.00 Strike: $1.18 $0.00
Disclosure

SEC source: 0000950170-25-024341 · ownership.xml · derivative · entry 1

van Es-Johansson An · CIK 0001795902 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,122

Underlying: Common Stock · 40,122 shares

Expires 2035-02-17

F1 · derivative.exercise_date: 1. The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:30 UTC
HEDRICK MARC HDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 400,489 $0.00 Strike: $1.18 $0.00
Disclosure

SEC source: 0000950170-25-024340 · ownership.xml · derivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,489

Underlying: Common Stock · 400,489 shares

Expires 2035-02-17

F1 · derivative.exercise_date: (1) The option vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 40,122 $0.00 Strike: $1.18 $0.00
Disclosure

SEC source: 0000950170-25-024339 · ownership.xml · derivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,122

Underlying: Common Stock · 40,122 shares

Expires 2035-02-17

F1 · derivative.exercise_date: 1. The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
September 13, 2024 Filed Sep 17, 2024 11:00 UTC PurchaseCommon Stock 4,000 $1.50 $5,996.00
Disclosure

SEC source: 0000950170-24-107008 · ownership.xml · nonDerivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,188

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.47 to $1.50 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 11:00 UTC PurchaseCommon Stock 6,285 $1.35 $8,511.78
Disclosure

SEC source: 0000950170-24-106605 · ownership.xml · nonDerivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,188

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.27 or $1.40 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 11, 2024 Filed Sep 12, 2024 20:30 UTC GrantStock Option (Right to Buy) · Derivative 3,650 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-24-105961 · ownership.xml · derivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,650

Underlying: Common Stock · 3,650 shares

Expires 2034-09-11

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
September 11, 2024 Filed Sep 12, 2024 20:30 UTC GrantStock Option (Right to Buy) · Derivative 3,650 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-24-105960 · ownership.xml · derivative · entry 1

van Es-Johansson An · CIK 0001795902 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,650

Underlying: Common Stock · 3,650 shares

Expires 2034-09-11

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
September 11, 2024 Filed Sep 12, 2024 20:30 UTC GrantStock Option (Right to Buy) · Derivative 3,650 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-24-105959 · ownership.xml · derivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,650

Underlying: Common Stock · 3,650 shares

Expires 2034-09-11

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
September 11, 2024 Filed Sep 12, 2024 20:30 UTC GrantStock Option (Right to Buy) · Derivative 3,650 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-24-105958 · ownership.xml · derivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,650

Underlying: Common Stock · 3,650 shares

Expires 2034-09-11

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
September 11, 2024 Filed Sep 12, 2024 20:30 UTC GrantStock Option (Right to Buy) · Derivative 3,650 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-24-105957 · ownership.xml · derivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,650

Underlying: Common Stock · 3,650 shares

Expires 2034-09-11

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
September 11, 2024 Filed Sep 12, 2024 20:30 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 46,074 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-24-105956 · ownership.xml · derivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,074

Underlying: Common Stock · 46,074 shares

Expires 2034-09-11

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.

Read SEC document
September 11, 2024 Filed Sep 12, 2024 20:30 UTC
HEDRICK MARC HDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 197,595 $0.00 Strike: $1.26 $0.00
Disclosure

SEC source: 0000950170-24-105954 · ownership.xml · derivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,595

Underlying: Common Stock · 197,595 shares

Expires 2034-09-11

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.

Read SEC document
September 11, 2024 Filed Sep 13, 2024 10:04 UTC PurchaseCommon Stock 12,500 $1.35 $16,875.00
Disclosure

SEC source: 0000950170-24-106180 · ownership.xml · nonDerivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,921

Read SEC document
September 11, 2024 Filed Sep 13, 2024 10:04 UTC PurchaseCommon Stock 5,000 $1.34 $6,681.00
Disclosure

SEC source: 0000950170-24-106179 · ownership.xml · nonDerivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,497

Read SEC document
September 10, 2024 Filed Sep 11, 2024 10:02 UTC
HEDRICK MARC HDirector · Chief Executive Officer
PurchaseCommon Stock 8,000 $1.23 $9,839.20
Disclosure

SEC source: 0000950170-24-105331 · ownership.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,425

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.22 or $1.23 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 10, 2024 Filed Sep 11, 2024 10:02 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
PurchaseCommon Stock 4,098 $1.27 $5,204.46
Disclosure

SEC source: 0000950170-24-105330 · ownership.xml · nonDerivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,815

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
GrantWarrants (Right to buy) · Derivative 9,804 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0000950170-24-057456 · ownership.xml · derivative · entry 2

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,804

Underlying: Common Stock Warrants · 9,804 shares

Expires not disclosed

F1 · derivative.expiration_date: The expiration date for 4,902 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,902 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.

F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants.

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
PurchaseCommon Stock 4,902 $2.04 $10,000.08
Disclosure

SEC source: 0000950170-24-057456 · ownership.xml · nonDerivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,717

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC
HEDRICK MARC HDirector · Chief Executive Officer
GrantWarrants (Right to buy) · Derivative 24,510 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0000950170-24-057455 · ownership.xml · derivative · entry 2

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,510

Underlying: Common Stock Warrants · 24,510 shares

Expires not disclosed

F1 · derivative.expiration_date: The expiration date for 12,255 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 12,255 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.

F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants.

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC
HEDRICK MARC HDirector · Chief Executive Officer
PurchaseCommon Stock 12,255 $2.04 $25,000.20
Disclosure

SEC source: 0000950170-24-057455 · ownership.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,425

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC GrantWarrants (Right to buy) · Derivative 24,510 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0000950170-24-057454 · ownership.xml · derivative · entry 2

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,510

Underlying: Common Stock Warrants · 24,510 shares

Expires not disclosed

F1 · derivative.expiration_date: The expiration date for 12,255 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 12,255 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.

F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants.

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC PurchaseCommon Stock 12,255 $2.04 $25,000.20
Disclosure

SEC source: 0000950170-24-057454 · ownership.xml · nonDerivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,421

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC GrantWarrants (Right to buy) · Derivative 19,608 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0000950170-24-057452 · ownership.xml · derivative · entry 2

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,608

Underlying: Common Stock Warrants · 19,608 shares

Expires not disclosed

F1 · derivative.expiration_date: The expiration date for 9,804 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 9,804 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.

F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants.

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC PurchaseCommon Stock 9,804 $2.04 $20,000.16
Disclosure

SEC source: 0000950170-24-057452 · ownership.xml · nonDerivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,497

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC GrantWarrants (Right to buy) · Derivative 9,804 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0000950170-24-057453 · ownership.xml · derivative · entry 2

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,804

Underlying: Common Stock Warrants · 9,804 shares

Expires not disclosed

F1 · derivative.expiration_date: The expiration date for 4,902 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,902 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.

F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants.

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC PurchaseCommon Stock 4,902 $2.04 $10,000.08
Disclosure

SEC source: 0000950170-24-057453 · ownership.xml · nonDerivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,903

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC GrantWarrants (Right to buy) · Derivative 8,334 $0.00 Strike: $1.79 $0.00
Disclosure

SEC source: 0000950170-24-057451 · ownership.xml · derivative · entry 2

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,334

Underlying: Common Stock Warrants · 8,334 shares

Expires not disclosed

F1 · derivative.expiration_date: The expiration date for 4,167 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,167 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.

F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants.

Read SEC document
May 08, 2024 Filed May 10, 2024 11:30 UTC PurchaseCommon Stock 4,167 $2.04 $8,500.68
Disclosure

SEC source: 0000950170-24-057451 · ownership.xml · nonDerivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,327

Read SEC document
February 22, 2024 Filed Feb 26, 2024 23:27 UTC GrantStock Option (Right to Buy) · Derivative 2,250 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0000950170-24-020419 · ownership.xml · derivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,250

Underlying: Common Stock · 2,250 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 23:26 UTC
LaFrance Norman D.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 24,073 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0000950170-24-020418 · ownership.xml · derivative · entry 1

LaFrance Norman D. · CIK 0001397768 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,073

Underlying: Common Stock · 24,073 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 23:26 UTC
HEDRICK MARC HDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 94,012 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0000950170-24-020417 · ownership.xml · derivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,012

Underlying: Common Stock · 94,012 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 23:25 UTC
Sims Andrew John Hugh MacIntyreChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 18,933 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0000950170-24-020416 · ownership.xml · derivative · entry 1

Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,933

Underlying: Common Stock · 18,933 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 23:25 UTC GrantStock Option (Right to Buy) · Derivative 2,250 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0000950170-24-020415 · ownership.xml · derivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,250

Underlying: Common Stock · 2,250 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 23:24 UTC GrantStock Option (Right to Buy) · Derivative 2,250 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0000950170-24-020414 · ownership.xml · derivative · entry 1

van Es-Johansson An · CIK 0001795902 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,250

Underlying: Common Stock · 2,250 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 23:24 UTC GrantStock Option (Right to Buy) · Derivative 2,250 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0000950170-24-020412 · ownership.xml · derivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,250

Underlying: Common Stock · 2,250 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 23:23 UTC GrantStock Option (Right to Buy) · Derivative 2,250 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0000950170-24-020411 · ownership.xml · derivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,250

Underlying: Common Stock · 2,250 shares

Expires 2034-02-22

F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting.

Read SEC document
November 20, 2023 Filed Dec 15, 2023 22:09 UTC
HEDRICK MARC HDirector · Chief Executive Officer
SaleCommon Stock 2,068 $1.96 $4,052.66
Disclosure

SEC source: 0001209191-23-058816 · doc4.xml · nonDerivative · entry 1

HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170

F1 · kind: The transactions reflect inadvertent trades made by the reporting person's custodian without authorization.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.9601 or $1.9768 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 16, 2023 Filed Nov 17, 2023 12:00 UTC PurchaseCommon Stock 1,000 $1.95 $1,950.00
Disclosure

SEC source: 0001209191-23-055638 · doc4.xml · nonDerivative · entry 2

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,160

Read SEC document
November 15, 2023 Filed Nov 17, 2023 12:00 UTC PurchaseCommon Stock 1,000 $1.77 $1,770.00
Disclosure

SEC source: 0001209191-23-055638 · doc4.xml · nonDerivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,160

Read SEC document
November 13, 2023 Filed Nov 15, 2023 12:00 UTC PurchaseCommon Stock 4,000 $1.43 $5,720.00
Disclosure

SEC source: 0001209191-23-055264 · doc4.xml · nonDerivative · entry 2

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,160

F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.44 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 10, 2023 Filed Nov 15, 2023 12:00 UTC PurchaseCommon Stock 2,000 $1.45 $2,900.00
Disclosure

SEC source: 0001209191-23-055264 · doc4.xml · nonDerivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,160

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.47 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 09, 2023 Filed Nov 13, 2023 12:00 UTC PurchaseCommon Stock 4,199 $1.59 $6,676.41
Disclosure

SEC source: 0001209191-23-054914 · doc4.xml · nonDerivative · entry 2

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,160

F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.59 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 08, 2023 Filed Nov 13, 2023 12:00 UTC PurchaseCommon Stock 5,000 $1.65 $8,250.00
Disclosure

SEC source: 0001209191-23-054914 · doc4.xml · nonDerivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,961

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.70 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 12:00 UTC PurchaseCommon Stock 6,000 $1.64 $9,840.00
Disclosure

SEC source: 0001209191-23-054650 · doc4.xml · nonDerivative · entry 2

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,961

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.68 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 06, 2023 Filed Nov 8, 2023 12:00 UTC PurchaseCommon Stock 1,395 $1.50 $2,092.50
Disclosure

SEC source: 0001209191-23-054650 · doc4.xml · nonDerivative · entry 1

Lenk Robert P · CIK 0001362635 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,961

Read SEC document
September 13, 2023 Filed Sep 15, 2023 11:00 UTC PurchaseCommon Stock 6,993 $1.43 $10,021.67
Disclosure

SEC source: 0001209191-23-049535 · doc4.xml · nonDerivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,693

Read SEC document
September 11, 2023 Filed Sep 12, 2023 11:00 UTC PurchaseCommon Stock 20,000 $1.70 $34,062.00
Disclosure

SEC source: 0001209191-23-049058 · doc4.xml · nonDerivative · entry 1

Petersen Greg · CIK 0001406815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,166

Read SEC document
June 06, 2023 Filed Jun 8, 2023 11:00 UTC PurchaseCommon Stock 1,000 $3.98 $3,980.00
Disclosure

SEC source: 0001209191-23-035267 · doc4.xml · nonDerivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,700

Read SEC document
May 03, 2023 Filed May 4, 2023 11:00 UTC PurchaseCommon Stock 2,500 $3.64 $9,101.50
Disclosure

SEC source: 0001209191-23-027213 · doc4.xml · nonDerivative · entry 1

Clowes Howard · CIK 0001806992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,700

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.